Tesar V, Rychlík I, Bartůnková J, Stejsakalová A, Zabka J, Janatková I, Fucíková T, Becvár R
I. interní klinika 1. LF UK a VFN, Praha.
Cas Lek Cesk. 1996 Jan 31;135(3):79-83.
Anti-neutrophil cytoplasmic antibodies (ANCA) define pathogenetically related group of renal vasculitides and glomerulonephritides mostly with serious prognosis. If unrecognized, these life-threatening diseases may cause loss of independent renal function and other dangerous extrarenal complications (e. g. pulmonary haemorrhage). We concentrated on the diagnosis, treatment and log-term follow-up of these patients.
Renal biopsy was performed in 46 ANCA-positive patients. Age and sex distribution, type of ANCA, organ involvement, renal biopsy findings, renal function and effect of therapy were analyzed in these patients. Twenty three patients suffered from renal vasculitis, most commonly Wegener's granulomatosis (14 patients) and microscopic polyarthritis (7 patients). IgA nephropathy (7 patients) and idiopathic necrotizing/crescentic glomerulonephritis (8 patients) prevailed in patients with limited renal involvement. Renal morphology and function was most seriously impaired in patients with Wegener's granulomatosis. Immunosuppressive treatment was able to control the activity of the disease with the negativization of ANCA and improvement or stabilization of renal function in more than 90% of patients.CONCLUSIONS. ANCA-positive renal vasculitis and glomerulonephritis is relatively common. Clinical signs of extrarenal involvement are present in about 50% of patients with ANCA-positive glomerulonephritis. Rapidly introduced immunosuppressive treatment effectively controls renal and extrarenal manifestations of the disease.
抗中性粒细胞胞浆抗体(ANCA)可界定一组在发病机制上相关的肾血管炎和肾小球肾炎,多数预后严重。若未被识别,这些危及生命的疾病可能导致独立肾功能丧失及其他危险的肾外并发症(如肺出血)。我们专注于这些患者的诊断、治疗及长期随访。
对46例ANCA阳性患者进行了肾活检。分析了这些患者的年龄和性别分布、ANCA类型、器官受累情况、肾活检结果、肾功能及治疗效果。23例患者患有肾血管炎,最常见的是韦格纳肉芽肿(14例)和显微镜下多血管炎(7例)。在肾受累有限的患者中,IgA肾病(7例)和特发性坏死性/新月形肾小球肾炎(8例)较为常见。韦格纳肉芽肿患者的肾形态和功能受损最为严重。免疫抑制治疗能够控制疾病活动,使超过90%的患者ANCA转阴,肾功能改善或稳定。
ANCA阳性的肾血管炎和肾小球肾炎较为常见。约50%的ANCA阳性肾小球肾炎患者存在肾外受累的临床体征。迅速采用的免疫抑制治疗可有效控制该疾病的肾内和肾外表现。